Oncolytics Biotech Files 6-K Report
Ticker: ONCY · Form: 6-K · Filed: Jun 27, 2024 · CIK: 1129928
| Field | Detail |
|---|---|
| Company | Oncolytics Biotech INC (ONCY) |
| Form Type | 6-K |
| Filed Date | Jun 27, 2024 |
| Risk Level | low |
| Pages | 1 |
| Reading Time | 1 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, foreign-private-issuer, routine-report
Related Tickers: ONC
TL;DR
Oncolytics Biotech (ONC) filed a 6-K, just a routine update for foreign issuers. Nothing major here.
AI Summary
Oncolytics Biotech Inc. filed a Form 6-K on June 27, 2024, reporting as a foreign private issuer. The company is based in Calgary, Alberta, Canada, and operates in the Pharmaceutical Preparations industry. This filing is made pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934.
Why It Matters
This filing provides routine updates for investors and regulatory bodies regarding the company's status as a foreign private issuer. It confirms their adherence to SEC reporting requirements.
Risk Assessment
Risk Level: low — This filing is a standard procedural report for a foreign private issuer and does not contain new financial or operational information that would typically indicate significant risk.
Key Players & Entities
- ONCOLYTICS BIOTECH INC (company) — Filer
- 0001129928-24-000050 (filing_id) — Accession Number
- 20240627 (date) — Filing Date
- 001-38512 (company_id) — SEC File Number
- Calgary, Alberta, Canada (location) — Company Headquarters
FAQ
What is the purpose of a Form 6-K filing?
A Form 6-K is a report of foreign private issuers required to be filed pursuant to Rule 13a-16 or 15d-16 of the Securities Exchange Act of 1934, typically to provide information that the registrant makes or is required to make public in its home country or to send or make public to its security holders.
What is the filing date of this 6-K report?
The filing date of this 6-K report is June 27, 2024.
Where is Oncolytics Biotech Inc. headquartered?
Oncolytics Biotech Inc. is headquartered in Calgary, Alberta, Canada.
What is the SEC file number for Oncolytics Biotech Inc.?
The SEC file number for Oncolytics Biotech Inc. is 001-38512.
Does Oncolytics Biotech Inc. file an annual report on Form 20-F or 40-F?
Oncolytics Biotech Inc. indicates it files its annual reports under cover of Form 20-F.
Filing Stats: 334 words · 1 min read · ~1 pages · Grade level 17 · Accepted 2024-06-27 12:16:54
Filing Documents
- form6kfdameetingpr.htm (6-K) — 18KB
- oncytypecmeetingpr.htm (EX-99.1) — 14KB
- 0001129928-24-000050.txt ( ) — 33KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. Oncolytics Biotech Inc. (Registrant) By s Kirk Look Date June 27, 2024 Kirk Look Chief Financial Officer